Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2010
07/22/2010US20100186102 Methods and compositions for post-transcriptional gene silencing
07/22/2010US20100186097 Cell-based rna interference and related methods and compositions
07/22/2010US20100184869 Method and kit for determining sirtuin modulating agents, sirtuin modulating procedure, sirtuin modulating compounds and compositions including the same
07/22/2010US20100184862 Prostacyclin derivatives
07/22/2010US20100184854 Platinum (iv) complexes and methods of use thereof
07/22/2010US20100184851 Inhibition of cell proliferation
07/22/2010US20100184841 Extended dicer substrate agents and methods for the specific inhibition of gene expression
07/22/2010US20100184840 Primary micro rna expression cassette
07/22/2010US20100184829 Rnai modulation of scap and therapeutic uses thereof
07/22/2010US20100184828 Methods and compositions for enhancing the efficacy and specificity of rna silencing
07/22/2010US20100184827 Methods and compositions for enhancing the efficacy and specificity of rna silencing
07/22/2010US20100184823 dsRNA For Treating Viral Infection
07/22/2010US20100184821 Compositions and Methods for Modulating Angiogenesis
07/22/2010US20100184820 Combinations comprising staurosporines
07/22/2010US20100184818 Photosensitizers for targeted photodynamic therapy
07/22/2010US20100184760 Benzoxazole kinase inhibitors and methods of use
07/22/2010US20100184745 Use of parthenolide derivatives as antileukemic and cytotoxic agents
07/22/2010US20100184706 Fap-activated chemotherapeutic compounds, and methods of use thereof
07/22/2010US20100184700 Preprocalcitonin antigen t epitopes
07/22/2010US20100184697 Peptide-based stat inhibitor
07/22/2010US20100184682 Composition and Methods for the Inhibition of Membrane Fusion by Paramyxoviruses
07/22/2010US20100184671 Binding molecules for the treatment of myeloid cell malignancies
07/22/2010US20100184657 Methods of treating epithelial lesions outside the stomach and intestines
07/22/2010US20100184656 Pantropic neurotrophic factors
07/22/2010US20100184642 Transgenic Plants Expressing Cobalamin Binding Proteins
07/22/2010US20100184638 Galanin Receptors and Brain Injury
07/22/2010US20100184621 Method and device for forming biologic cell aggregates
07/22/2010US20100184619 Method for analyzing organelle-localized protein and material for analysis
07/22/2010US20100184605 Plant farnesyltransferases
07/22/2010US20100184227 Pluripotent stem cells obtained by non-viral reprogramming
07/22/2010US20100184226 Media conditioning for improving gene delivery efficiency to differentiating embryonic stem cells
07/22/2010US20100184225 Use of a cellular extract for a mitotic remodeling of chromosomes
07/22/2010US20100184224 Plant cell wall loosening activity of group 2/3 allergens of grass pollen
07/22/2010US20100184223 Biomaterial based on a hydrophilic polymeric carrier
07/22/2010US20100184222 Method for preparing biological tissue
07/22/2010US20100184221 Method for isolation of cell, serum-free culture medium for cell, and method for culture of cell
07/22/2010US20100184220 Prevascularized tissue transplant constructs for the reconstruction of a human or animal organ
07/22/2010US20100184219 Methods and Apparatuses Relating to Cell Culture Media
07/22/2010US20100184218 Isolation and Culture-Expansion Methods of Mesenchymal Stem/Progenitor Cells From Umbilical Cord Blood, And Differentiation Method of Umbilical Cord Blood-Derived Meschymal Stem/Progenitor Cells Into Various Mesenchymal Tissues
07/22/2010US20100184217 Stem cell lines, their application and culture methods
07/22/2010US20100184216 hTERT GENE EXPRESSION REGULATORY GENE
07/22/2010US20100184215 Modified thioredoxin
07/22/2010US20100184214 Method for production of dendritic cell
07/22/2010US20100184213 Apocrine cell line
07/22/2010US20100184212 Human embryonic stem cell derived mesoderm-like epithelium transitions to mesenchymal progenitor cells
07/22/2010US20100184211 Tumour-Associated Peptides that Bind to MHC Molecules
07/22/2010US20100184210 Method for isolating cells
07/22/2010US20100184209 Compositions and methods for inhibiting gene silencing by rna interference
07/22/2010US20100184185 Isolated luciferases and the use thereof
07/22/2010US20100184182 Method for preparing biological tissue
07/22/2010US20100184148 In vitro germinal centers
07/22/2010US20100184147 METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD
07/22/2010US20100184144 Immunoglobulin production
07/22/2010US20100184141 Serum-free Stable Transfection and Production of Recombinant Human Proteins in Human Cell Lines
07/22/2010US20100184140 cells comprising a translation system comprising an synthetase enzymes encoded by a nucleotide sequence and the complementary polynucleotide sequence; protein biosynthesis
07/22/2010US20100184128 Production of products of pharmaceutical interest in plant cell cultures
07/22/2010US20100184116 Fluorescent protein
07/22/2010US20100184114 Method for screening allergic disease-related molecule and cell lines to be used in the method
07/22/2010US20100184113 Controlling osteogenesis by inhibition of osteogenic suppressors
07/22/2010US20100184107 Protein trafficking
07/22/2010US20100184097 4,5-bis(4-methoxyphenyl)imidazole compound inducing differentiation of myoblasts or muscle fibers into neuron cells, a pharmaceutical composition including said compound, a method of inducing neuron cells differentiation and a screening method for identifying additional compound useful for inducing neuron cells differentiation
07/22/2010US20100184094 Use of mdck cells in the evaluation of cholesterol modulators
07/22/2010US20100184082 Antibody and immunoassays for determining the presence of delta9-tetrahydrocannabinol
07/22/2010US20100184051 Methods of generating pluripotent cells from somatic cells
07/22/2010US20100184033 Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
07/22/2010US20100184032 Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof
07/22/2010US20100184021 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
07/22/2010US20100183765 Asparaginase enzyme variants and uses thereof
07/22/2010US20100183750 Fortification of plants with folates by metabolic engineering
07/22/2010US20100183735 Method for inducing selectively suppressed immune response to transplanted tissue or cells
07/22/2010US20100183704 dsRNA FOR TREATING VIRAL INFECTION
07/22/2010US20100183699 Compositions and methods to cross link polymer fibers
07/22/2010US20100183683 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
07/22/2010US20100183665 Promoterless cassettes for expression of alpha virus structural proteins
07/22/2010US20100183653 Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof
07/22/2010US20100183651 Broadly Representative Antigen Sequences and Method for Selection
07/22/2010US20100183647 Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor
07/22/2010US20100183644 Tumour-Associated Peptides that Bind to MHC Molecules
07/22/2010US20100183637 fusion molecule based on novel taa variant
07/22/2010US20100183618 Anti-epha2 antibody
07/22/2010US20100183616 Antibodies against interleukin-1 beta
07/22/2010US20100183615 Cross-species-specific bispecific binders
07/22/2010US20100183612 Methods of treatment using ctla4 mutant molecules
07/22/2010US20100183611 Targeted cryptosporidium biocides
07/22/2010US20100183609 Taci-immunoglobulin fusion proteins
07/22/2010US20100183602 Induction of Tolerogenic Phenotype in Mature Dendritic Cells
07/22/2010US20100183592 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions
07/22/2010US20100183590 LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
07/22/2010US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines
07/22/2010US20100183583 Galk1s as modifiers of the pten/akt pathway and methods of use
07/22/2010US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport
07/22/2010US20100183577 Enzyme replacement therapy for treating lysosomal storage diseases
07/22/2010US20100183575 Compositions and Methods for Producing Adaptive Regulatory T Cells
07/22/2010US20100183573 membrane polypeptide for use in designing therapeutic for proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders; cancer, immunological-related, blood-related and skin-related disorders
07/22/2010US20100183572 Cell capable of expressing lacritin at high level
07/22/2010US20100183571 Treatment of multiple sclerosis using placental stem cells
07/22/2010US20100183570 Non-embryonic stem cells and uses thereof
07/22/2010US20100183568 Method for production of hepatic-lobule-like cell cluster from adipose-tissue-derived cell
07/22/2010US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof
07/22/2010US20100183566 METHOD FOR EFFICIENT TRANSFER OF HUMAN BLASTOCYST-DERIVED STEM CELLS (hBS CELLS) FROM A FEEDER-SUPPORTED TO A FEEDER-FREE CULTURE SYSTEM
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 1827